Brief: Indaptus Therapeutics Provides Clinical Update
04/09/2025 22:28
Indaptus Therapeutics Inc INDP.O: INDAPTUS THERAPEUTICS PROVIDES CLINICAL UPDATE INDAPTUS THERAPEUTICS INC - DECOY20 MONOTHERAPY INDUCES PARTIAL RESPONSE IN CANCER PATIENT INDAPTUS THERAPEUTICS INC - DECOY20 COMBINATION WITH PD-1 INHIBITOR SHOWS CONSISTENT SAFETY Source text: ID:nGNX3hDWMD Further company coverage: INDP.O